- Home
- VANI vs LTH Comparison
VANI vs LTH Comparison
Compare VANI & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- LTH
- Stock Information
- Founded
- VANI 1998
- LTH 1992
- Country
- VANI United States
- LTH United States
- Employees
- VANI N/A
- LTH N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LTH Hotels/Resorts
- Sector
- VANI Health Care
- LTH Consumer Discretionary
- Exchange
- VANI Nasdaq
- LTH Nasdaq
- Market Cap
- VANI 68.1M
- LTH N/A
- IPO Year
- VANI 2014
- LTH 2021
- Fundamental
- Price
- VANI $1.26
- LTH $28.60
- Analyst Decision
- VANI Strong Buy
- LTH Buy
- Analyst Count
- VANI 1
- LTH 13
- Target Price
- VANI $4.00
- LTH $34.42
- AVG Volume (30 Days)
- VANI 66.4K
- LTH 2.0M
- Earning Date
- VANI 05-13-2025
- LTH 05-08-2025
- Dividend Yield
- VANI N/A
- LTH N/A
- EPS Growth
- VANI N/A
- LTH 174.52
- EPS
- VANI N/A
- LTH 0.96
- Revenue
- VANI N/A
- LTH $2,730,319,000.00
- Revenue This Year
- VANI N/A
- LTH $14.57
- Revenue Next Year
- VANI N/A
- LTH $10.86
- P/E Ratio
- VANI N/A
- LTH $29.76
- Revenue Growth
- VANI N/A
- LTH 18.58
- 52 Week Low
- VANI $0.91
- LTH $15.64
- 52 Week High
- VANI $2.09
- LTH $34.99
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- LTH 42.34
- Support Level
- VANI $1.13
- LTH $28.22
- Resistance Level
- VANI $1.16
- LTH $29.59
- Average True Range (ATR)
- VANI 0.05
- LTH 0.78
- MACD
- VANI 0.02
- LTH -0.10
- Stochastic Oscillator
- VANI 92.86
- LTH 16.89
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.